Abstract
Purpose
We investigated whether hilar radioaerosol deposition affects the clearance rate of technetium-99m-labeled diethylenetriaminepentaacetic acid (99mTc-DTPA) from peripheral alveolar regions.
Materials and methods
A total of 38 patients underwent 99mTc-DTPA inhalation lung scintigraphy. Six region of interest (ROI) patterns were adopted: ROI 1 was outlined around the entire hemithorax, and ROIs 2–6 were outlined around the hemithorax but excluded square ROIs of different size in the hilar region. Half-times (T½) were calculated with time-activity curves using onecompartment and two-compartment analyses. The T½ of ROIs 1–5 were plotted against the T½ of ROI 6, and regression lines were obtained with the least-squares method. The absolute values of the differences between surveyed values and regression line were calculated. The Wilcoxon test for trend and a single linear regression model were used to determine statistical significance.
Results
There were significant reductions in the absolute values of the differences between surveyed values and regression line from ROIs 1–5 by one-component analysis and the fast component of two-compartment analysis (P < 0.001).
Conclusion
Our results suggest that the deposition of radioaerosol in the hilar region affects the clearance rate of 99mTc-DTPA from the alveoli in damaged lungs. The hilar region should be excluded from ROIs when alveolar epithelial permeability is evaluated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
O’Doherty MJ, Peters AM. Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury. Eur J Nucl Med 1997;24:81–87.
Smith RJ, Hyde RW, Waldman DL, Freund GG, Weber DA, Utell MJ, et al. Effect of pattern of aerosol inhalation on clearance of technetium-99m-labeled diethylenetriamine pentaacetic acid from the lungs of normal humans. Am Rev Respir Dis 1992;145:1109–1116.
Salvaggio JE. Inhaled particles and respiratory disease. J Allergy Clin Immunol 1994;94:304–309.
Agnew JE, Pavia D, Clarke SW. Mucus clearance from peripheral and central airways of asymptomatic cigarette smokers. Bull Eur Physiopathol Respir 1986;22:263–267.
Krasnow A, Isitman A, Collier D, Effros R, Hellman R, Palmer D, et al. Diagnostic applications of radioaerosols in nuclear medicine. In: Freeman L, editors. New York: Raven; 1993. p. 123–193.
Oberdorster G, Utell MJ, Morrow PE, Hyde RW, Weber DA. Bronchial and alveolar absorption of inhaled 99mTc-DTPA. Am Rev Respir Dis 1986;134:944–950.
Mogulkoc N, Brutsche MH, Bishop PW, Murby B, Greaves MS, Horrocks AW, et al. Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP). Thorax 2001;56:916–923.
Waldman DL, Weber DA, Oberdorster G, Grago SR, Utell MJ, Hyde RW, et al. Chemical breakdown of technetium-99m DTPA during nebulization. J Nucl Med 1987;28:378–382.
Dolovich PEng MA. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care 2000;45:597–608.
Coates G, O’Brodovich H. Extrapulmonary radioactivity in lung permeability measurements. J Nucl Med 1987;29:903–906.
Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985;4:87–90.
Bennett WD, Ilowite JS. Dual pathway clearance of 99mTc-DTPA from the bronchial mucosa. Am Rev Respir Dis 1989;139:1132–1138.
Effros RM, Mason GR. Measurements of pulmonary epithelial permeability in vivo. Am Rev Respir Dis 1983;127:S59–S65.
Jones JG, Minty BD, Royston D. The physiology of leaky lungs. Br J Anaesth 1982;54:705–721.
Mason GR, Effros RM, Uszler JM, Mena I. Small solute clearance from the lungs of patients with cardiogenic and noncardiogenic pulmonary edema. Chest 1985;88:327–334.
Gellert A, Winter R, Uthayakumar S. Bronchoalveolar lavage and clearance of 99mTc-DTPA in asbestosis. 1984;39:709.
Susskind H, Rom WN. Lung inflammation in coal miners assessed by uptake of 67Ga-citrate and clearance of inhaled 99mTc-labeled diethylenetriamine pentaacetate aerosol. Am Rev Respir Dis 1992;146:47–52.
Rinderknecht J, Shapiro L, Krauthammer M, Taplin G, Wasserman K, Uszler JM, et al. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis 1980;121:105–117.
Rosso J, Guillon JM, Parrot A, Denis M, Akoun G, Mayaud C, et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med 1992;33:81–87.
Jefferies AL, Coates G, O’Brodovich H. Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med 1984;311:1075–1080.
Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, du Bois RM. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797–802.
Jones JG, Minty BD, Lawler P, Hulands G, Crawley JC, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980;1:66–68.
Susskind H, Weber DA, Volkow ND, Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest 1991;100:903–909.
Susskind H, Weber DA, Lau YH, Park TL, Atkins HL, Franceschi D, et al. Impaired permeability in radiationinduced lung injury detected by technetium-99m-DTPA lung clearance. J Nucl Med 1997;38:966–971.
Coates G, O’Brodovich H, Dolovich M. Lung clearance of 99mTc-DTPA in patients with acute lung injury and pulmonary edema. J Thorac Imaging 1988;3:21–27.
Steyn PF, Gillette S, Gillette EL. Biological half-life of aerosolized Tc-99m diethylenetriaminepentaacetate in various lung regions of clinically normal beagles. Am J Vet Res 1994;55:1371–1376.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ogi, S., Gotoh, E., Uchiyama, M. et al. Influence of hilar deposition in the evaluation of the alveolar epithelial permeability on 99mTc-DTPA aerosol inhaled scintigraphy. Jap J Radiol 27, 20–24 (2009). https://doi.org/10.1007/s11604-008-0288-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-008-0288-x